| 000 | 01751nam a2200133Ia 4500 | ||
|---|---|---|---|
| 008 | 220620s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a9783040000000 | ||
| 245 | 0 | _aCOVID-19: Current Challenges and Future Perspectives | |
| 546 | _aEnglish[eng] | ||
| 650 | _aCOVID-19||SARS-CoV-2||hepatitis B and C||cirrhosis||chronic kidney disease||alcohol-related liver disease||nonalcoholic steatohepatitis||necrosis||MDR-TB||clinical trials||IL-6 inhibitors||tocilizumab||cytokine release syndrome||cytokine storm||operational research||health systems||SORT IT||pandemics||training||pandemic||endemic||tuberculosis||impact||control||overview||malaria||preparedness||Africa||emergency||fecal calprotectin||bowel perforation||D-Dimer||thrombosis||ischemia||efficacy||safety||kaletra||lopinavir/ritonavir||meta-analysis||coronavirus||SARS-CoV-1||MERS||SARS||influenza||healthcare worker||healthcare personnel||general practitioners||medical doctor||heart transplant||CMV||Chagas disease||infection||severity||respiratory viruses||coinfections||health care workers||Philippines||rhinovirus||severe acute respiratory syndrome coronavirus 2||plasmodium falciparum||differential diagnosis||cognitive bias||diagnostic reasoning||recurrence||reinfection||Bangladesh||Kenya||Nairobi||presumptive tuberculosis||TB treatment outcomes||HIV||antiretroviral therapy||EpiCollect5||Malawi||Lilongwe||Zimbabwe||Harare||real-time operational research||ethics||research capacity building||India||Nepal||post-acute COVID-19 syndrome||COVID-19 vaccines||mortality||epidemiology||public health||healthcare workers||attitudes||perceptions||knowledge||n/a | ||
| 700 | _aLeggat, Peter||Frean, John||Blumberg, Lucille | ||
| 856 | _uhttps://mdpi.com/books/pdfview/book/5094 | ||
| 942 | _cEB | ||
| 999 |
_c30093 _d30093 |
||